-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Jasper Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2019 to Q3 2024.
- Jasper Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$19.9M, a 2.72% decline year-over-year.
- Jasper Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$68.7M, a 5.85% decline year-over-year.
- Jasper Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$68.9M, a 34.5% decline from 2022.
- Jasper Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$51.2M, a 39% decline from 2021.
- Jasper Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$36.8M, a 78.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)